Early Stage Trial Finds Malaria Vaccine Promotes Immune Response In Young Children, Study Says
An experimental vaccine was found to promote immune responses to malaria in young children in Mali, Reuters reports. According to the news service, “The vaccine, which uses an immune system booster called an adjuvant from British drugmaker GlaxoSmithKline, targets the malaria parasite as it is actively infecting red blood cells and causing fever and illness” (Steenhuysen, 2/3).